
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
[ Tue, Jan 03rd 2023 ]: WOPRAI
Yatin Suneja Upgraded (ACAD) to Strong Buy and Held Target at $22 on, Jan 3rd, 2023


🞛 This publication is a summary or evaluation of another publication
Yatin Suneja of Guggenheim, Upgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Strong Buy and Held Target at $22 on, Jan 3rd, 2023.
Yatin has made no other calls on ACAD in the last 4 months.
There are 5 other peers that have a rating on ACAD. Out of the 5 peers that are also analyzing ACAD, 3 agree with Yatin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Uy Ear of "Mizuho" Maintained at Hold with Decreased Target to $15 on, Wednesday, December 21st, 2022
- Tessa Romero of "JP Morgan" Maintained at Hold with Decreased Target to $17 on, Monday, November 14th, 2022
- Esther Hong of "Loop Capital" Initiated at Hold and Held Target at $17 on, Tuesday, November 1st, 2022
These are the ratings of the 2 analyists that currently disagree with Yatin
- Salveen Richter of "Goldman Sachs" Downgraded from Hold to Strong Sell and Decreased Target to $12 on, Friday, November 4th, 2022
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $21 on, Thursday, November 3rd, 2022